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 2 
INTRODUCTION 
 
The polyamines putrescine, spermidine and spermine are present in almost all 
cells and have important roles in protein synthesis, cell division and cell growth (Fig. 1). 
Putrescine is synthesized from L-ornithine in a reaction catalysed by ornithine 
decarboxylase, the rate-limiting enzyme in polyamine biosynthesis. Putrescine and 
decarboxylated S-adenosyl methionine are substrates for the synthesis of spermidine, 
which is a precursor of spermine. Polyamines are organic polycations that are 
protonated at physiological pH and can potentially interact with a variety of cellular 
targets including nucleic acids and proteins [1 – 4].  
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Fig. 1 Structure of polyamines. 
 
The endogenous polyamines putrescine, spermidine and, in particular, spermine 
modulate a number of ion channels [5, 6]. Spermine and spermidine are present in high 
concentrations in the nervous system, and uptake and depolarization-induced release of 
polyamines from brain slices has been reported [7, 8]. Extracellular spermine has 
multiple effects at the NMDA subtype of glutamate receptor, including stimulation that 
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increases the size of NMDA receptor currents and voltage-dependent block [9 – 15].  
Activation of NMDA receptors is associated with the induction of various forms of 
synaptic plasticity, including some forms of long-term potentiation and long-term 
depression, processes that may underlie learning and memory [16 – 18]. NMDA 
receptors are a subtype of ligand-gated ionotropic glutamate receptors including 
subtypes of AMPA and kainite receptors [19]. Although they share common structural 
features, NMDA receptors have several characteristics different from the other two 
subtypes of glutamate receptors; 1) Not only glutamate but also glycine are necessary 
for activation of NMDA receptors; 2) NMDA receptors show high permeability to Ca2+; 
and 3) NMDA receptor activity is blocked by Mg2+ at resting membrane potential and 
the block is relieved by depolarization [19]. 
At native NMDA receptors expressed on cultured neurons, there is considerable 
variability in the degree of stimulation by spermine of individual neurons [11 – 14]. This 
may be due to the expression of multiple forms of the NMDA receptor composed of 
different combinations of subunits. The NR1 family consists of eight splice variants of 
the NR1 gene [20 – 23], seven of which were originally termed NR1A - NR1G [24]. The 
NR2 family consists of NR2A, NR2B, NR2C, and NR2D cDNAs isolated from rat brain 
[25 – 28]. High active NMDA receptor channel is formed in vitro by coexpression of NR1 
and NR2 subunits [25, 26, 29, 30], although the NR1 subunit alone exhibits a very small 
response in the Xenopus oocyte expression system [21, 31]. In accord with this, most 
brain regions express both NR1 and NR2 subunits. The NR1 subunit mRNA is found 
ubiquitously in the brain during development. Mutant mice defective in the NR1 
subunit died shortly after birth and failed to develop whisker-related neuronal patterns 
in the trigeminal nuclei [32, 33]. At the embryonic stages, the NR2B subunit mRNA is 
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expressed in the entire brain, and NR2D subunit mRNA is expressed in the 
diencephalons and brainstem [34]. After birth, the NR2A subunit mRNA appears in the 
entire brain, and NR2C subunit mRNA mainly in the cerebellum. After birth, 
expression of NR2B subunit mRNA becomes restricted to the forebrain, ant that of the 
NR2D subunit mRNA is strongly reduced. The NR2B subunit knockout mice died 
within 1 day after birth [35]; disruption of NR2A subunit of the mouse does not 
appreciably affect the growth and mating of the mice, but results in reduction of 
hippocampal LTP and spatial learning [36]; the NR2D subunit mutant mice grow 
normally, but exhibit reduced spontaneous behavioral activity [37]; the deficiency of 
either the NR2A or NR2C subunit causes no remarkable behavioral abnormality, but 
the disruption of both NR2A and NR2C results in impairment of motor coordination [38]. 
Thus, multiple NR2 subunits are major determinants of the NMDA receptor channel 
diversity, and the molecular compositions and functional properties of NMDA receptor 
channels are different depending on the brain regions and developmental stages [39 – 
41]. 
Each subunit consists of an extracellular N-terminal regulatory (R) domain, 
agonist binding (S) domain, channel forming domain and intracellular domain (Fig. 2). 
There are four membrane (M1 – M4) regions in the channel forming domain, and second 
membrane segment (M2) is thought to form a re-entrant loop and contribute to the 
narrowest constriction of the channel (Fig. 2) [19]. The NMDA receptors are probably 
tetramers composed of two molecules each of NR1 and NR2 subunits [19, 42, 43]. 
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Fig. 2 Structure of NMDA receptor subunits. Each NMDA subunit contains two large 
extracellular domains-the regulatory R domain (itself comprised of R1 and R2) and the agonist binding 
S domain (itself comprised of S1 and S2). The transmembrane domain is comprised of M1 – M3, and a 
re-entrant loop (M2). The receptor is gated by the co-agonist glutamate (Glu) and glycine (Gly). The 
NMDA receptors are probably heterotetramers composed of two molecules each of NR1 and NR2 
subunits. 
 
The multiple effects of spermine on NMDA receptors are summarized in Fig. 3. 
spermine potentiates NMDA currents in the presence of saturating concentrations of 
glycine (glycine-independent stimulation; mechanism 1 in Fig. 3), an effect that involves 
an increase in the frequency of channel opening and a decrease in the desensitization of 
NMDA receptors [12, 14]. A second effect involves an increase in the affinity of NMDA 
receptors for glycine (glycine-dependent stimulation; mechanism 2 in Fig. 3) [11, 44]. A 
third effect of spermine, a decrease in affinity for glutamate (mechanism 3 in Fig. 3) [45], 
has been observed at some recombinant NMDA receptors. The mechanism underlying 
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this effect is not known, but it may reflect an increased rate of dissociation of glutamate 
from the receptor in the presence of spermine. In this case, spermine could have a 
marked effect on the time course of NMDA responses at the synapse, where the 
duration of the response is dependent on the rate of unbinding of glutamate from the 
receptors.  
In addition to stimulation, voltage-dependent inhibition by extracellular 
spermine was seen at native NMDA receptors (in the absence of extracellular Mg2+), 
possibly representing a direct block of the ion channel by spermine (mechanism 4 in Fig. 
3) [11 – 13, 46]. The strong voltage-dependent inhibition may be due to binding of 
spermine within the ion channel pore at a site close to, or overlapping with, the binding 
site for extracellular Mg2+. There is no evidence to suggest that intracellular polyamines 
block NMDA channels, although spermine, applied extracellularly, produces an 
incomplete block that probably reflects permeation of spermine through NMDA 
channels (Fig. 3) [11, 47].  
Stimulation by spermine is dependent on the type of NR1 splice variant and the 
type of NR2 subunit present in NMDA receptors [10, 45, 48 – 51]. Only receptors 
expressed from splice variants, such as NR1A, that lack a 21-amino-acid insert encoded 
by exon 5 show glycine-independent stimulation by spermine [48, 49]. Furthermore, the 
various effects of spermine are differentially manifested in heteromeric NR1A/NR2 
receptors containing different NR2 subunits (Fig. 3) [10, 45, 51]. NMDA receptors are 
inhibited by protons, with a tonic inhibition of about 50% at physiological pH (7.3 – 7.5) 
[52, 53]. Sensitivity to protons, like sensitivity to stimulation by spermine, is influenced 
by the presence of exon 5 in NR1. Variants that contain the insert (such as NR1B) are 
less sensitive to protons than are variants that lack the insert [54]. The 
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glycine-independent form of spermine stimulation is influenced by extracellular pH. At 
NR1A/NR2B receptors, spermine produces a larger fold increase in macroscopic currents 
at acidic pH than at alkaline pH [54]. Because there is a greater inhibition of NMDA 
receptors by protons at acidic pH, part of the mechanism of action of spermine may 
involve relief of tonic proton inhibition (Fig. 3) [54].  
 
 
Spermine Ca2+out
in
H+ I fenprodil
Na+
Spermine
Gly
1
4
Glu
N N
Effect of spermine
1. Glycene-independent stimulation no
yes
low high low low
yes
yes
no
no
no
no
NR1A/NR2A NR1A/NR2B NR1A/NR2C NR1A/NR2D
Spermine
2 3
3. Decrease affinity for glutamate
2. Glycene-dependent stimulation
4. Voltage-dependent inhibition
5. Relative affinity for ifenprodil
no yes no no
yes yes no no
 
Fig. 3 Modulation of NMDA receptors. Diagram of NMDA receptor is showing effects of 
spermine, proton, ifenprodil. Numbers indicate various macroscopic effects of these modulators. 
Spermine has four macroscopic effects that are differentially controlled by NR2 subunits. 
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Ifenprodil is a novel NMDA antagonist that selectively inhibits NR1/NR2 
receptors containing the NR2B subunit [55, 56].  Ifenprodil acts as a noncompetitive, 
partial, and voltage-independent antagonist [55, 57, 58]. Its potency strongly depends 
on the extracellular pH and is only weakly affected by the insertion of the NR1 exon 5 
[59, 60]. Finally, ifenprodil displays use dependence such that binding of glutamate 
increases binding of ifenprodil and vice versa [61, 62]. 
There are complex interactions between spermine, protons, and ifenprodil at 
NMDA receptors. Spermine stimulation may involve relief of proton inhibition [54], 
whereas ifenprodil inhibition may involve an increase in proton inhibition [60]. Using 
site-directed mutagenesis, identified that a cluster of acidic residues located near the 
exon-5 splice site influence sensitivity to spermine and pH, and also identified several 
residues in the proximal part of the amino terminus of NR1 that appear to form part of 
the ifecprodil binding site. Based on these results, a model is proposed that the amino 
terminus NR1 is similar to leucine/isoleucine/valine binding protein (LIVBP), 
containing two regulatory domains, which termed R1 and R2 domain [63, 64]. This 
region, containing the binding sites for spermine and ifenprodil, may influence the 
downstream S1 and S2 domains that constitute the glycine binding pocket. Residues in 
the M3-M4 loop, and the M2 pore-forming region of NR1 subunit have also been found 
to influence sensitivity to spermine and pH [63, 64]. In this study, using spermine and 
various mutants of NMDA receptor in the surface of the channel and ion channel pore, 
the structure of ion channel pore consisting of NR1A and NR2B has been studied at the 
exciting and resting states. 
Glutamate neurotoxicity may have two components, possibly corresponding to 
the acute swelling and delayed degeneration observed in vivo [65]. Opening of 
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membrane cation channels presumably leads to a Na+ influx, membrane depolarization, 
a secondary influx of Cl- and water, and excitotoxic cell swelling [65 – 67]. The second 
component, marked by delayed neuronal degeneration, is mediated by the toxic effects 
produced by excessive Ca2+ influx [67]. The influx of extracellular Ca2+, together with 
any Ca2+ release triggered from intracellular stores, would elevate cytosolic free Ca2+. 
Elevated cytosolic Ca2+ then activates several enzymes, such as calpain 1 [68], 
phospholipase [69], xanthine oxidase [70], capable of either directly or indirectly 
destroying cellular structure [71]. Pharmacological studied suggest that NMDA receptor 
activation is essential to most of glutamate neurotoxicity, consistent with the 
observation that NMDA receptors largely mediate the increase in intracellular Ca2+ 
produced by excitatory amino acids on neurons [72]. Indeed, there is evidence from 
animal studies for marked neuroprotedtive effects of NMDA receptor antagonists in 
models of ischemic stroke, epilepsy, and Parkinsonism [73]. Among NMDA channels 
blockers, memantine has been used clinically in the treatment of Alzheimer’s disease 
[74]. 
Antagonists have been discovered or developed that act at various sites on NMDA 
receptors, including competitive antagonists at the glutamate and glycine sites and a 
diverse range of organic compounds that act as channel blockers. The channel pore is 
also blocked by Mg2+ and is permeable to Ca2+ [19]. The M2 loop region in NR1 and NR2 
subunits is a critical determinant of divalent cation permeability and Mg2+ block. In 
particular, asparagines residues in this region form part of an Mg2+ binding site and 
contribute to the selectivity filter of the channel [19, 75]. These asparagines residues 
have also been found to influence block by organic channel blockers such as dizocilpine 
(MK-801), memantine, and polyamine derivatives such as 
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N1,N4,N8-tribenzylspermidine [11, 76 – 80]. Residues in M1, M3, and M4, in particular 
M3, have also been found to affect block by MK-801 and polyamine derivatives [78, 81]. 
These residues may contribute directly to a binding site for the blockers and/or be 
involved in gating of the channel [78, 79, 81]. 
To study the structure of NMDA channels and to look for novel classes of 
antagonists, we developed several polyamine derivatives, including bisethylpolyamines 
[47], N1-Dansylspermine [82], benzylpolyaines [76], and anthraquiones [79]. The 
anthraquinone triamine AQ34 was an NMDA channel blocker with a novel profile. 
However, its potency at NMDA receptors was relatively low (IC50 = 7 mM at NR1/NR2A 
receptors at -70 mV). In the present work, we tried to develop more potent polyamine 
blockers based on AQ34. We found that tetraamine derivatives of anthraquinone and 
anthracene are potent NMDA antagonists (Fig. 4). Furthermore, we studied 
determinants in both NR1 and NR2B subunits that influence block by these polyamine 
derivatives. The results were consistent with other work showing that NR1 (Asn616) 
and NR2B (Asn616), but not NR2B (Asn615), make the narrowest contribution of 
NMDA channel, and that the M3 segments from the two subunits, which form the outer 
vestibule, are likely staggered relative to each other in the vertical axis of the channel 
[83 – 86]. 
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Fig. 4. Structures and activity of NMDA channel blockers. IC50 values were determined from 
concentration-inhibition curves at NR1/NR2A receptors in oocytes voltage-clamped at –70 mV. 
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NMDA clones and site-directed mutagenesis. 
 
The NR1 clone used in these studies is the NR1A variant [21], which lacks the 
21-amino acid insert encoded by exon 5. This clone, and some of the NR1 mutants in the 
M2 and M1-M2 linker region [21, 75], were gifts from Dr. S. Nakanishi (Osaka 
Bioscience Institute, Osaka, Japan). The wild-type mouse and rat NR2B clones [26, 29] 
were gifts from Drs. M. Mishina (Graduate school of medicine, University of Tokyo, 
Tokyo, Japan) and P. H. Seeburg (Center for molecular biology, University of Heidelberg, 
Heidelberg, Germany). The preparation of most other NR1 and NR2B mutants has been 
described previously [64, 78, 79 88 – 91]. Site-directed mutagenesis to construct new 
NR1 and NR2B mutants was carried out by the method of Ho et al. (1989) [87] using the 
polymerase chain reaction, with Pfu polymerase purchased from Stratagene. Amino 
acids are numbered from the initiator methione in each subunit. Mutations were 
confirmed by DNA sequencing using a Seq 4×4 personal sequencing system (Amersham 
Biosciences) over approximately 300 nucleotides containing the mutation. Amino acids 
are numbered from the initiator methione in NR1 and NR2B clones. A list of 
oligonucleotide primers used for new mutant in this study is shown in Tables. 1, 2. 
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Table 1. NR1A mutant primers. 
 
L562C:   5’-CAGAGCACATGCTGGTTGCTAGTAGGACTG-3’ 
H571C:   5’-CTGTCAGTTTGTGTGGTGGCTGTGATGCTG-3’ 
V575C:   5’-GTGGTGGCTTGTATGCTGTACCTGCTGGAC-3’ 
F639C:   5’-TGGGCTGGTTGCGCCATGATCATAGTGGCT-3’ 
I643C:   5’-GCCATGATCTGTGTGGCTTCCTACACTGCC-3’ 
V644C:   5’-ATGATCATATGTGCTTCCTACACTGCCAAC-3’ 
G815C:   5’-AACATGGCATGCGTCTTCATGCTGGTGGCT-3’ 
M818A:   5’-GGGGTCTTCGCGCTGGTGGCTGGAGGCATC-3’ 
V820A:   5’-TTCATGCTGGCGGCTGGAGGCATCGTAGCT-3’  
I824C:   5’-GCTGGAGGCTGCGTAGCTGGGATTTTCCTC-3’ 
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Table 2. NR2B mutant primers. 
 
A556G:   5’-CCATTCAGCGGTGACGTGTGGGTGATGATG-3’ 
D557N:   5’-TTCAGCGCTAACGTGTGGGTGATGATGTTT-3’ 
M561L:   5’-GTGTGGGTGTTGATGTTTGTGATGCTGCTC-3’ 
M561C:   5’-GTGTGGGTGTGTATGTTTGTGATGCTGCTC-3’ 
F563V:   5’-GTGATGATGGTTGTGATGCTGCTCATTGTT-3’ 
V564A:   5’-ATGATGTTTGCGATGCTGCTCATTGTTTCT-3’ 
L566A:   5’-TTTGTGATGGCGCTCATTGTTTCTGCGGTG-3’ 
L567A:   5’-GTGATGCTGGCCATTGTTTCTGCGGTGGCT-3’ 
S570C:   5’-ATTGTTTGTGCGGTGGCTGTCTTTGTCTTT-3’ 
V574C:   5’-GCGGTGGCTTGCTTTGTCTTTGAATACTTC-3’ 
W635C:   5’-GTGTCAGTGTGTGCCTTCTTTGCTGTCATT-3’ 
F638C:   5’-GTGTGGGCCTTCTGTGCTGTCATTTTCCTG-3’ 
F642C:   5’-GCTGTCATTTGCCTGGCCAGCTACACTGCC-3’ 
L643C:   5’-GTCATTTTCTGTGCCAGCTACACTGCCAAC-3’ 
N806L:   5’-AATGAGAAGCTTGAGGTGATGAGCAGCCAG-3’ 
E807Q:   5’-GAGAAGAATCAGGTGATGAGCAGCCAGCTG-3’ 
V808A:   5’-AAGAATGAGGCGATGAGCAGCCAGCTGGAC-3’ 
D814C:   5’-AGCCAGCTGTGCATCGACAATATGGCAGGT-3’ 
I815A:   5’-CAGCTGGACGCCGACAATATGGCAGGTGTC-3’ 
D816N:   5’-CTGGACATCAACAATATGGCAGGTGTCTTC-3’ 
N817L:   5’-GACATCGACCTTATGGCAGGTGTCTTCTAT-3’ 
M818S:   5’-GGACATCGACAATTCGGCAGGTGTCTTCT-3’ 
A819G:   5’-GACAATATGGGAGGTGTCTTCTATATGTTG-3’ 
V821A:   5’-AATATGGCAGGTGCCTTCTATATGTTGGGG-3’ 
Y823C:   5’-GGTGTCTTCTGTATGTTGGGGGCAGCCATG-3’ 
M829A:   5’-GCCGCCGCCCTCAGCCTCATCACCTTCATC-3’ 
L825A:   5’-GGTGTCTTCTATATGAGCGGGGCAGCCA-3’ 
S832A:   5’-GCCATGGCCCTCGCCCTCATCACCTTCATC-3’ 
 
Xenopus oocyte injection and recording. 
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The preparation of capped cRNAs and the preparation, injection, and 
maintenance of oocytes were carried out as described previously [55]. Oocytes were 
injected with NR1 plus NR2 cRNAs in a ratio of 1:5 (0.1-0.4 ng of NR1 plus 0.5-2 ng of 
NR2).  Macroscopic currents were recorded with a two-electrode voltage clamp using a 
GeneClamp 500 amplifier (Molecular Devices, Union City, CA).  Electrodes were filled 
with 3 M KCl and had resistances of 0.4 to 4 MΩ.  Oocytes were continuously 
superfused with a saline solution (96 mM NaCl, 2 mM KCl, 1.8 mM BaCl2, and 10 mM 
HEPES, pH 7.5), and in most experiments, oocytes were injected with 40 mM 
K+-BAPTA (100 nl; pH 7.0-7.4) on the day of recording.  Receptors were activated by 
superfusion of glutamate and glycine (10 µM). 
Data analysis and curve fitting were carried out using Axograph (Molecular 
Devices) or SigmaPlot (SPSS Inc., Chicago, IL). To obtain IC50 values of polyamine 
derivatives, concentration-inhibition curves were fit to the following equation: 
 
IGlu + blocker/IGlu = 1/[1 + ([blocker]/IC50)nH] 
 
In which IGlu is the response to glutamate and IGlu + blocker is the response to glutamate 
measured in the presence of the blocker. We used this equation, which is constrained to 
100% inhibition of the response to the agonist, based on the assumption that the 
blockers produce a complete inhibition at the various receptors studied. 
 To study the voltage dependence of block, voltage ramps were constructed by 
ramping the command signal from –150 to +40 mV over 2 s. Leak currents, measured in 
the absence of agonist and blockers, were digitally subtracted. We chose concentrations 
of blockers that gave a 60% to 90% inhibition at -70 mV with a particular mutant. 
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Synthesis of Anthraquinone- and Anthracene-Tetraamines.  
The anthraquinone-spermine and homospermine (AQ343 and AQ444) were 
prepared by coupling of anthraquinone p-nitrophenyl ester and tetraamines (spermine 
and homospermine) in CHCl3 [92, 93]. The anthracene [N1-(9-anthracenylmethyl)] 
derivatives Ant343 and Ant444 were synthesized as described previously [94]. The 
structures of each compound were confirmed by spectral data and elemental analysis.  
Preferred Conformation of AQ343, AQ444, Ant343, and Ant444. 
The conformational stability of the four compounds was determined by 
molecular dynamics (MD) simulation (Sander molecule in AMBER8 package; University 
of California, San Francisco, San Francisco, CA, 2004) at 310 K (37°C) in water phase 
using CPU Intel Xeon 1.70 Ghu 2 CPU, OS; Red Hat Linux 7.3.2. The MD simulation 
was started by the minimization of 100 steps with the steepest decent method. The 
temperature was raised to 310 K at 80 ps and was maintained at 310 K. The simulation 
continued for 10 ns. The coordinates were stored in the output file every 1 ps, and total 
10,080 conformers were obtained. The analysis of conformational stability was executed 
with the 9000 conformers obtained at 310K. The conformation whose appearance 
probability was the highest was adopted as the most stable conformation with MMTSB 
tool set (M. Feig, J. Karanicolas, and C. L. Brooks, III, National Institutes of Health 
Research Resource, 2001). The "gaff.dat" force-field parameters [95] were used for bond, 
angle, torsion, and van der Waals parameters, and Gaussian 03 program (revision C.02., 
2004; Gaussian Inc., Wallingford, CT) was used for calculation of the electrostatic 
potentials.  
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Introduction 
 
The structure of ion channel pore of NMDA receptor consisting of NR1A and 
NR2B was studied by measuring the activity of various mutants of NR1A and NR2B in 
the presence and absence of spermine. It was found that the channel pore mainly 
consisted of the M3 transmembrane segment of NR1A and NR2B and the M1 segment of 
NR2B at both exciting and resting states. The amino acid residues involved in spermine 
stimulation at -20 mV and block at -100 mV on the M3 transmembrane segment were 
different, suggesting that amino acid residues interacting with the complex of spermine 
and R domain for stimulation and spermine itself for block are different. The former 
was mainly recognized by the M3 segment and the M2 loop of NR1A and the M3 
segment of NR2B, and the latter was mainly recognized by the M3 segment of NR1A 
and the M1 and M3 segments and the M2 loop of NR2B. Mutations on W608 and W611 
in NR1A and W607 and W610 in NR2B in the M2 loop showed different effects: W608 
and W611 in NR1A were involved in spermine stimulation and W607 and W610 in 
NR2B in spermine block. These results indicate that the relative position of M1 and M3 
transmembrane segment and M2 loop in NR1A and NR2B against the channel pore is 
asymmetric. In some mutants located on the M3 transmembrane segment of NR1A or 
NR2B, affinity for both glycine and glutamic acid increased, suggesting that NR1A and 
NR2B function as a heterodimer. 
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Results 
 
Determination of amino acid residues in the surface of the channel and ion channel pore 
which are involved in spermine stimulation at -20 mV and inhibition at -100 mV. 
 
We made a series of individual point mutations in and around the 
membrane-spaning and pore-forming loop region of the NR1A and NR2B subunits. The 
mutants were constructed in most cases to alter the functional side chains, for example 
by neutralizing the charge (E-to-Q, D-to-N), removing an aromatic ring (W-to-L, Y-to-L), 
removing a hydroxyl group (S-to-A, T-to-A) or substituting other amino acid with A or C. 
We screened each mutation by measuring spermine stimulation at -20 mV and 
spermine block at -100 mV with 100 mM spermine. If spermine stimulation decreased ³ 
20% and spermine block recovered ³ 40% in the mutants compared with those of wild 
type NMDA receptor, it is judged that mutated amino acid residues are involved in 
spermine stimulation and block, respectively.  
Results on NR1A mutants are shown in Figs. 5 and 7. Amino acid residues P557 
on pre-M1, W608, W611 and N616 on M2 loop, F639, V644, S646, Y647, T648, A653, 
V656 and L657 on the M3 segment, D669 and L808 on post-M3 and post-M4 region 
were involved in spermine stimulation, while F554 on pre-M1, W563 on the M1 segment, 
N650, A652 and L655 on the M3 segment, and E662 and T807 on post-M3 and pre-M4, 
and G815 on the M4 segment were involved in spermine block. The results indicate that 
the M3 transmembrane segment of NR1A mainly makes the channel pore at both 
exciting and resting states and amino acid residues interacting with the complex of 
spermine and R-domain for stimulation and spermine itself for block are different. 
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Results on NR2B mutants are shown in Fig.6 and 7. Amino acid residues S645, 
A648, L650 and A652 on the M3 segment, N616 on M2 loop and D814 on pre-M4 region 
were involved in spermine stimulation, while 9 amino acid residues on M1, 7 amino acid 
residues on M3, 2 amino acid residues on M2 loop, 3 amino acid residues on pre-M1 
region, and 7 amino acid residues on post-M3 and pre-M4 region were involved in 
spermine block. The results indicate that the M1 transmembrane segment together 
with the M3 transmembrane segment of NR2B appears on the surface of channel pore 
at the resting state. The results also suggest that NR2B rather than NR1A mainly 
makes the restricted part of the channel pore because both the M1 and M3 
transmembrane segments of NR2B are involved in the channel block by spermine (Fig. 
7). 
As for the relative position of M2 loop in NR1A and NR2B, W608 and W610 in 
NR1A were involved in spermine stimulation, and W607 and W610 in NR2B in 
spermine block. The results indicate that the relative position of M2 loop in NR1A and 
NR2B against the channel pore is asymmetric. 
As for the amino acid residues on the M1 and M3 segments involved in spermine 
stimulation and block, the effects were examined by changing the spermine 
concentration at -20 mV. As shown in Figs. 8A and 8B, spermine inhibition became 
greater when spermine concentration is increased in the mutants involved in spermine 
stimulation. However, in the mutants involved in spermine block, spermine stimulation 
became greater when spermine concentration is increased except NR1A L644A (Figs. 8C 
and 8D). The results suggest that the structure of the channel pore does not change 
significantly at -20 mV and -100 mV. 
I-V curves were then constructed with mutants in which spermine stimulation 
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decreased. As shown in Fig. 9, currents of the mutants NR1A(T648A)/NR2B and 
NR1A/NR2B(S645A) in the presence of spermine were lower than that in the absence of 
spermine from +50 mV to -150 mV, while the current of wild type NMDA receptor in the 
presence of spermine was lower than that in the absence of spermine only at the resting 
potential. I-V curves were then constructed with mutants in which spermine inhibition 
decreased. Currents of the mutants NR1A(W563)/NR2B, NR1A(A652T)/NR2B, 
NR1A/NR2B(V566A) and NR1A/NR2B(T647A) in the presence of spermine increased 
greatly compared with the currents in the absence of spermine (Fig. 9). The results 
confirm that the structure of channel pore does not change significantly at both exciting 
and resting states because mutants function similarly at both states. 
 
Determination of amino acid residues which are involved in ifenprodil and proton 
inhibition. 
 
It is known that spermine enhances, and ifenprodil and proton inhibit the 
activity of NMDA receptor through their binding to the R-domain of NMDA receptor 
and amino acid residues involved in these effects are partially overlapped [54, 55, 58, 63, 
64, 88]. Thus the effects of ifecprodil and H+ on the activity of NMDA receptor were 
tested using the mutants involved in spermine stimulation. As shown in Fig. 10, 
inhibition by ifenprodis was reduced more clearly in the mutants of NR2B than in the 
mutants of NR1A except NR1A(F638C), while inhibition by proton was weakened in 
NR1A F639, NR1A V656 and NR2B A648 mutants. The results suggest that the binding 
of ifenprodil to the R-domain of NR2B is more effective that that to the R domain of 
NR1A, while the binding of proton to the R domain of NR1A and NR2B was at the 
 23 
specific site because of the size of H+. 
 
Interaction between agonist-binding domain and the channel pore 
 
There are several mutants on M3 transmembrane segments, such as NR1A 
T648A and NR1A L657A, which exhibit significant currents without agonists, i.e, leaky 
mutants [78]. Because some of these mutants on the M3 transmembrane segment are 
also involved in spermine stimulation, we tested whether effective concentration of 
agonists, that is, glycine and glutamate, is changed or not. As shown in Fig. 11, effective 
concentration of both glycine and glutamate decreased greatly in both mutants of NR1A 
and NR2B. The results indicate that mutants of NR1A such as NR1A(A653T)/NR2B and 
NR1A(L657A)/NR2B not only influence the affinity of glycine but also that of glutamate. 
Similarly, mutants of NR2B such as NR1A/NR2B(L650A) and NR1A/NR2B(A648G) not 
only influence the affinity of glutamate but also that of glycine. The results strongly 
suggest that NR1A and NR2B function as a heterodimer, because mutation in the 
channel pore of NR1A influences the affinity of glutamate, an agonist of NR2B. 
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Discussion 
 
We studied the structure of ion channel pore consisting of NR1A and NR2B by 
measuring the effect of spermine on NMDA receptor activities with various NMDA 
receptor mutants. Our data are consistent with the proposal that NR1A Asn616 and 
NR2B Asn616 form narrowest constriction of the channel with the NR1A and NR2B 
subunits arranged asymmetrically and that the M3 segment of NR1A and NR2B is 
strongly involved in the recognition of blocker [78, 85, 86]. In this study, we found that 
the M1 segment of NR2B makes the channel pore together with the M3 segments of 
NR1A and NR2B, and that two tryptophan molecules on the M2 loop function differently 
in terms of spermine stimulation and block. The results also suggest that the binding of 
spermine to the R-domain of NR1A is more effective that that to the R domain of NR2B, 
while the binding of ifenprodil to the R domain of NR2B is more effective that that to 
the R domain of NR1A, although spermine and ifenprodil bound to the R-domains of 
both NR1A and NR2B (unpublished results). This is based on an idea that the R-domain 
of NR1A and NR2B interacts with own channel forming region. 
We have previously identified amino acid residues involves in the channel block 
by anthraquinone- and anthracene-tetraamines [91]. Most of amino acid residues on the 
M1 and M3 segments involved in the reduction of channel block corresponded with 
those involved in spermine block, and some amino acid residues involved in the 
enhancement of channel block corresponded with those involved in spermine 
stimulation of the NMDA receptor activity. 
It was also shown that spermine which functions as channel blocker interacts 
with many amino acid residues on the M3 segments of NR1A and NR2B, the M1 
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segment of NR2B, the M2 loop of NR2B, and those located on the surface of the 
membrane. On the contrary, spermine-R-domain complex which functions as a 
stimulator of the channel opening mainly interacts with amino acid residues on the M3 
segments of NR1A and NR2B and the M2 loop of NR1A. The results strongly suggest 
that R-domain interacts with the limited place of the channel pore region. Furthermore, 
the M1 segment of NR2B appeared on the surface of the channel pore region at both -20 
mV and -100 mV, because amino acid residues on the M1 segment involved in the 
channel block by spermine functioned at both membrane potentials. Based on the 
results, we constructed a channel opening model (Fig. 12). It is thought that R-domain 
is located on the surface of the membrane [97]. However, the R-domain may be located 
inside the channel. If the R-domain is located inside the channel, our results may be 
understandable more easily. 
The structure of the channel pore-forming domain of NR1 and NR2 has been 
studied extensively using the substituted cysteine accessibility method (SCAM) [84, 78, 
79]. Our structural model of the channel pore region of NR1A and NR2B shown in Fig.7 
was constructed based on the computer analysis [78], and it was similar to the model of 
NR1 and NR2C [79]. Our results of spermine interaction with amino acid residues 
located on the surface of the membrane (pre-M1, post-M3 and pre-M4 of NR1A and 
NR2B) and those on M3 segment of NR1A and NR2B and on M1 segment of NR2B also 
support the structural model shown in Fig.7. 
It has been also reported that the functional unit of NMDA receptor is a 
heterdimer of NR1 and NR2 [43, 98]. Since the mutants of the M3 segment of NR1A 
influence the affinity of not only glycine but also glutamate and the mutants of the M1 
and M3 segments of NR2B influence the affinity of not only glutamate but also glycine, 
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out results strongly support the above idea that NR1 and NR2 function as a unit. In 
summary, new finding on the channel pore were successfully obtained with the 
experiments using the mutants of NMDA receptor and spermine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 35 
 
 
 
 
Chapter 3 
 
 
Comparative studies of anthraquinone- and 
anthracene- tetraamines as blockers of 
N-methyl-D-aspartate receptors 
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Introduction 
 
Anthraquinone spermine [N1-(anthraquinone-2-carbonyl)spermine; AQ343], 
anthraquinone homospermine [N1-(anthraquinone-2-carbonyl)homospermine; AQ444], 
anthracene spermine [N1-(9-anthracenylmethyl)sermine; Ant343], and antracene 
homospermine [N1-(9-anthracenylmethyl)homospermine; Ant444] were found to be  
potent antagonists of recombinant NMDA receptors. The effects of both anthraquinone 
(AQ)- and anthracene (Ant)-tetraamines were reversible and voltage-dependent. 
Results of experiments using mutant NR1 and NR2 subunits of NMDA receptor 
identified residues that influence block by AQ- and Ant- tetraamines. The results 
indicate that the polyamine tail is crucial for block by AQ- and Ant- tetraamines. The 
head group may be positioned at the selectivity filter/narrowest constriction of the 
channel and polyamine tail penetrates this constriction into the inner vestibule below 
the level of the selectivity filter. Residues in the outer vestibule of the NR1 subunit were 
more strongly involved in block by AQ- and Ant-tetraamines than residues in the 
corresponding region of NR2B. Several amino acid residues in the inner vestibule, below 
the level of the selectivity filter of NR1 and NR2B, affected block by AQ444, Ant343, and 
Ant444, but they did not affect block by AQ343. AQ-tetraamines could permeate the 
channel at very negative membrane potentials when the narrowest constriction of the 
channel was expanded by replacing the Asn residue at Asn616 of NR1 and NR2B with 
Gly, whereas Ant-tetraamines did not easily pass through the channel, apparently 
because of differences in the relative position of the head groups on AQ- and 
Ant-polyamines. 
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Results 
 
Voltage-dependent block by AQ343, AQ444, Ant343, and Ant444. 
 
We reported previously that the triamine AQ34 is a blocker of NMDA receptors. 
However, its potency was relatively low (IC50 at -70 mV = 7 mM at NR1/NR2A). Thus, we 
studied the effects of replacing the anthraquinone (AQ) moiety with anthracene (Ant). 
As shown in Fig. 13, AQ343, AQ444, Ant343, and Ant444 inhibited NR1/NR2A receptors, 
and the inhibition was reversible and voltage-dependent. The IC50 values for AQ343, 
AQ444, Ant343, and Ant444 at NR1/NR2A receptors were 0.4, 0.6, 0.06, and 0.02 mM, 
respectively (Table 3). The results suggest that the potency of inhibition depends on the 
number of positive charges because the NH moiety of the amide (-CONH-) group in the 
AQ derivatives is not protonated at pH 7.5 [99] (thus, they have only three positive 
charge), whereas all four amines of the Ant derivatives are protonated at this pH (thus, 
they have four positive charges). 
 
Subtype-selective inhibition. 
 
To determine the subunit selectivity and potency of block by AQ343, AQ444, 
Ant343, and Ant444, we measured concentration-inhibition curves at NR1/NR2 
receptors containing the NR2A, NR2B, NR2C, and NR2D subunits and at the 
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor expressed from 
the GluR1 subunit. For AQ343 and AQ444, the polyamines were more potent at 
NR1/NR2A, NR1/NR2B, and NR1/NR2D receptors that at NR1/NR2C and GluR1 
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receptors (Fig.14, A and B). However, the profile was different with Ant343 and Ant444. 
For Ant343, potency was in the order NR1/NR2A > NR1/NR2D ≈  NR1/NR2B » 
NR1/NR2C > GluR1, and for Ant444, it was NR1/NR2A ≈ NR1/NR2B > NR1/NR2D » 
GluR1 ≈ NR1/NR2C (Fig. 14; Table 3). Thus, both AQ- and Ant-tetramines are more 
potent at NR1/NR2A, NR1/NR2B, and NR1/NR2D than at NR1/NR2C and GluR1. 
 
Identification of amino acid residues that influence block by AQ- and Ant-tetraamines. 
 
We carried out experiments to identify the amino acid residues in NR1 and NR2B 
that influence block by the tetraamines using a series of NR1 and NR2B mutants 
(Fig.15 and 16). We previously identified residues that differentially affect block by 
memantine, MK-801, tribenzylspermidine, and AQ34 [78, 79]. For the present study, we 
made an additional 14 mutants in NR2B. Thus, the effects of the tetraamines on 24 
NR1 mutants and 27 NR2B mutants were examined with two different concentrations 
of each blocker.  
In Figs. 15 and 16, residues at which mutations reduce block by AQ- and 
Ant-tetraamines by more than 15% compared with wild type are highlighted by an open 
box; mutations that increase block by a particular polyamine are highlighted by a black 
box. As shown in Figs. 15 and 17, block by AQ343, AQ444, Ant343, and Ant444 shared 
many common determinants in the NR1 subunit. These residues were located in the 
outer vestibule and at the selectivity filter/narrowest constriction of the channel 
(Asn616 in NR1). Eight mutations, at NR1 Phe558, Trp563, Asn616, Asn650, Ala652, 
Leu655, Asp669, and Thr807, reduced block by the four tetraamines and also by AQ34 
and tribenzylspermidine [78, 79]. This suggests that these residues are involved in the 
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recognition of all of these compounds. With regard to residues in the inner vestibule 
below the levels of the selectivity filter, several residues affected block by Ant343 and 
Ant444. In the region, only Glu621 in NR1 influenced block by AQ343 and AQ444. The 
results support the idea that the polyamine tail passes through the selectivity filter and 
can interact with residues below that level, whereas the head group cannot easily 
permeate the narrow constriction. The results also suggest that the structure of the 
head group and/or the angle between the head group and the polyamine tail shown in 
Fig. 18 influence the interaction of the tail with the residues below the selectivity filter. 
The profiles measured with mutations in NR2B were different from those in NR1 
(Figs. 16 and 17). Mutations at NR2B Trp559, Asn616, and Asn649 decreased the block 
by all four tetraamines and also byAQ34, AQ33b, and tribenzylspermidine [78, 79]. 
Mutations at only a few residues in the outer vestibule in NR2B reduced block by 
AQ343, AQ444, Ant343, and Ant444 compared with residues in the corresponding 
region of NR1. In contrast, mutations at several residues, especially to the smaller 
residues Ala or Gly, enhanced block by AQ343 and Ant343 but did not affect block by 
AQ444 and Ant444. This may reflect differences in the space occupied by these 
compounds (Fig. 6). The “width” of the polyamine derivatives was estimated in Fig. 18 
and revealed that AQ343 (8.3 Å) and Ant343 (8.2 Å) were greater than those of AQ444 
(6.5 Å) and Ant444 (7.3 Å). The differences between NR1 and NR2B are consistent with 
the idea that the M3 segments from the two subunits are staggered relative to each 
other in the vertical axis of the channel [85].  
Mutations at Gly597, Thr601, Trp607, and Val620 in the inner vestibule of NR2B 
affected block by AQ444, but only a mutation at Thr601 reduced block by AQ343. This 
may be due to a difference of the structure of AQ343 and AQ444 in which AQ444 is 
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straighter than AQ343 as well as having a longer polyamine tail (Fig.18). With regard to 
Ant343 and Ant444, residues Asp668 and Gln812 in the outer vestibule and Thr601 and 
val620 in the inner vestibule were more strongly involved in block by Ant444 than by 
Ant343. It may be that the longer homospermine tail (444) penetrates deeper into the 
inner vestibule than the spermine (343) tail. This idea is supported by the observation 
that block by Ant343 was enhanced if G597 or Val620 in NR2B were replaced by a Glu 
residue, which is larger than Gly or Val and could potentially interact with the terminal 
amine of Ant343 in these mutants (Figs. 16 and 17). 
 
Effects of mutations at the selectivity filter. 
 
An Asn to Gln mutation at the critical asparagines in the M2 loop of NR1 
(N616Q) reduced block by AQ343, AQ444, Ant343, and Ant444 (Fig. 15); however, 
substitution of Gly for Asn enhanced the block by Ant343, but not by AQ343, AQ444, 
and Ant444. There are two asparagines residues (Asn615 and Asn616) at a similar 
position in the M2 loop of NR2B, which also contribute to the selectivity filter and Mg2+ 
binding site [17]. We also reported data consistent with the proposal that NR1 Asn616 
and NR2B Asn616 make the narrowest constriction of the channel [78]. An N616G 
mutation in NR2B increased block by AQ343 and Ant343, did not influence block by 
AQ444, and decreased block by Ant444. An N616Q mutation at this position decreased 
block by all four compounds. The results may be explained as follows: narrowing of the 
channel by substitution of Gln for Asn at Asn616 in NR1 or NR2B decreased the block 
by these compounds, maybe due to the disturbance of penetration of polyamine tail into 
the inner vestibule. Expanding of the channel (NR1 N616G, NR2B N615G, and NR2B 
 41 
N616G) enhanced block by AQ343 and Ant343 preferentially. This may reflect 
occupancy of a wider space by AQ343 and Ant343 than by AQ444 and Ant444 (Fig. 18). 
We carried out experiments to determine whether the AQ and Ant polyamines 
could permeate wild-type and mutant NMDA channels (Fig. 19). To do this, we 
measured block and looked for relief of block at extreme negative membrane potentials 
[82]. At wild type receptors, block was voltage-dependent and was almost complete from 
-100 to -150 mV (Fig. 7). Howerver, by expanding the size of channel pore with 
NR1(N616G) and NR2B(N615G) or NR2B(N616G), AQ343, and , in particular, AQ444 
showed significant permeation of the channel manifest as a partial relief of block at very 
negative membrane potentials (Fig. 19). In contrast, there was little or no permeation of 
Ant343 and Ant444 at the mutant channels (Fig. 19) 
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Discussion 
 
 
NMDA receptor-mediated neurotoxicity contributes to a variety of neurological 
disorders as well as cell death after trauma and stroke. Thus, there are continuting 
efforts to develop selective NMDA channel blockers for clinical use. NMDA channels are 
blocked by a large number of structurally dissimilar organic compounds, including 
ketamine, phencyclidine, MK-801, memantine, and various spider toxins and polyamine 
derivatives [76, 79, 80, 100, 101]. Among these blockers, memantine has been used 
clinically in the treatment of Alzheimer’s disease [74]. Memantine is a readily reversible 
and selective channel blocker [102] that may have better clinical utility and fewer side 
effects than the very high-affinity and slowly reversible blockers such as MK-801 [79]. 
In this study, we looked for new, rapidly reversible and selective NMDA channel 
blockers with a higher potency than memantine. It was found that AQ343, AQ444, Ant 
343, and Ant444 are reversible, voltage-dependent NMDA blockers, particularly at 
NR1/NR2A and NR1/NR2B receptors, and only weakly block GluR1 AMPA receptors. 
Both the polyamine tail and the head group are important for the activity of these 
compounds. By changing the structure of both the polyamine tail and the head group, 
we would like to develop rapidly reversible and more selective NMDA channel blockers 
for potential clinical application. Because of the relatively slow exchange time of the 
bath solution using oocyte recordings, we did not attempt to measure the dissociation of 
these various blockers or to compare their rates of dissociation with other blockers such 
as MK-801, ketamine, and phencyclidine. Nonetheless, it is clear that the Ant- and 
AQ-polyamines dissociate much faster that MK-801. 
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Memantine is weakly selective for NMDA receptor subtypes, with a rand order of 
potency NR1/NR2D ≈ NR1/NR2C > NR1/NR2B > NR1/NR2A [103]. It has been reported 
that NR2A is expressed widely in the brain and NR2B in forebrain. However, NR2C is 
predominantly in the cerebellum and NR2D in neonatal stages [34]. AQ- and 
Ant-tetraamines preferentially blocked NR1/NR2A, NR1/NR2B, and NR1/NR2D. 
Tribenzylspermidine [76] preferentially blocked NR1/NR2A or NR1/NR2B receptors 
compared with those containing NR2C or NR2D. Thus, these types of blockers may have 
different in vivo profiles compared with memantine because of their somewhat different 
subtype selectivity. 
We probed the interaction of the AQ- and Ant-tetraamines with the NMDA 
channel by using a large series of NR1 and NR2B mutants. We found that mutations in 
the M3 region in the outer vestibule of NR1 generally had greater effects on the blockers 
than mutations in the equivalent region of NR2B. The polyamine tail may pass through 
the narrowest constriction of the channel, and its interaction with the M2 loop and 
inner vestibule may be dependent on the angle of head group and polyamine tail. In this 
regard, AQ444 and Ant444, which have a longer polyamine tail than AQ343 and Ant343, 
were influenced by residues deeper in the inner vestibule. The data are consistent with 
the proposal that NR1 Asn616 and NR2B Asn616 form the narrowest constriction of the 
channel, with the NR1 and NR2 subunits arranged asymmetrically and that the M3 
region in the outer vestibule of NR1 is strongly involved in the recognition of blockers 
[19, 78, 104]. However, some amino acid residues in M3 of NR2B also affected block by 
AQ343 and Ant 343 but not AQ444 and Ant444. This may be due to the difference of 
space occupied by these compounds, because substitution of larger amino acid residues 
with smaller ones enhanced block by AQ343 and Ant343 but not by AQ444 and Ant444. 
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With regard to the potencies of the four compounds, one of the important factors 
is the number of positive charges-the degree of inhibition was greater with Ant343 was 
more potent than AQ444, and Ant444 was more potent than Ant343. The results 
suggest that the distance and the angle between the head skeleton and the NH2 group 
in the polyamine tail are important for interactions with the NMDA channel (Fig. 6). In 
conclusion, subtle molecular shape differences involving the angle between the 
polycyclic ring and the linear polyamine tail as well as the length of the polyamine tail 
itself are key parameters to be considered in the design of polyamine-derived NMDA 
receptor antagonists. 
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